Sample Case #5

• Q. A sponsor submits a supplemental application for a new indication for an approved therapy. The original application was granted a waiver on the basis that the approved indication does not occur in children. Is the new supplemental application exempted from having to address the1998 Rule due to the previous waiver?

Previous slide

Next slide

Back to first slide

View graphic version